Use the new COUPON CODE: SEPT2022CQBCOUPON to obtain a 25% discount on a QBank subscription.
Coupon expires Sep 30th, 2022.

Topics: QBank for the PEBC QE Part 1

The QBank for the PEBC QE Part 1 covers 9 subjects:

  • Ethical, Legal, and Professional Responsibilities
  • Patient Care
  • Product Distribution
  • Practice Setting
  • Health Promotion
  • Knowledge and Research Application
  • Communication and Education
  • Inter and Intra-professional collaboration
  • Quality and Safety

The QBank contains carefully prepared, classic simulated Multiple Choice Questions (MCQs) for each of the Topics listed below

Ethical, Legal, and Professional Responsibilities

  • Documentation- Clarification of patient past medical history and allergies (Documentation In Practice)
  • Ethics- Beneficence (Uphold Ethical Principles)
  • Ethics- Confidentiality (Uphold Ethical Principles)
  • Ethics- Conflicts of interest (Uphold Ethical Principles)
  • Ethics- Euthanasia and Assisted suicide (Uphold Ethical Principles)
  • Ethics- Fidelity (Uphold Ethical Principles)
  • Ethics- Justice (Uphold Ethical Principles)
  • Ethics- Nonmaleficence (Uphold Ethical Principles)
  • Ethics- Palliative care and End of life care (Uphold Ethical Principles)
  • Ethics- Patient autonomy (Uphold Ethical Principles)
  • Ethics- Pharmacist conscience clause (Uphold Ethical Principles)
  • Ethics- Veracity (Uphold Ethical Principles)
  • Ethics-Advocacy for the patient (Uphold Ethical Principles)
  • Law- Drugs that may be sold without a prescription (Practice within Legal requirements)
  • Law- Food and Drug Act legislation (Practice within Legal requirements)
  • Law- Narcotic Control Regulations (Practice within Legal requirements)
  • Law- Privacy Act (Practice within Legal requirements)
  • Situation- Patient with addiction (Practice Dilemmas)
  • Situation- Patient with aggressive behavior (Practice Dilemmas)

Patient Care

  • Administration—Abdominal wall clinical anatomy for insulin injections (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Administration—Administration of the drugs to the patient using necessary skills (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Administration—Elbow anatomy for intravenous injections (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Administration—Gastrointestinal system physiology for oral medications (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Administration—Injection technical skills (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Administration—Medications best taken after food (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Administration—Medications best taken before food (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—calculating the Glasgow coma scale (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—calculating the mini mental status score (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Cause of drug problems in a wrong prescription (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Cause of drug problems in medications taken unnecessarily (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Cause of drug problems in wrong dosages (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Centor criteria for streptococcal pharyngitis (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Child-Pugh score interpretation (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—detecting and interpreting swollen lymph nodes (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—detecting and interpreting xanthomas (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—detecting blue man syndrome (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—detecting dehydration (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—detecting dermatitis (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Detecting emergency hypertension on BP check (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—detecting exophthalmos and interpreting findings (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—detecting gastroenteritis based on clinical presentation (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting Bicarbonate level in acidosis and alkalosis (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting complete blood count in Anemia (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting Coombs tests (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting duodenoendoscopy (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—interpreting edema findings (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting EKG in atrial fibrillation (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting EKG in QT prolongation (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting elevated cardiac CK-MB (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting elevated cardiac Troponin (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting ELISA (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting Erythrocyte sedimentation rate (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting Estrogen levels (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting fecal fat (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting Pap smear (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting prostatic specific antigen (PSA) (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting Triglycerides (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting TSH, Free T4, and T3 (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting Uric Acid (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting Urinalysis (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—Interpreting urine ketones in diabetes (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Assessment—vaginal bleeding differential diagnosis (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Abatacept (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Acyclovir (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Adriamycin (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Alendronate/Bisphosphonates (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Aliskiren (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Allopurinol (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Alprazolam/Benzodiazepines (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Aluminum hydroxide (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Amiodarone (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Amitriptyline/all tricyclic antidepressants (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Amlodipine/all dihydropyridine (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Amphotericin B (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Aripiprazole (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Atropine (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Azathioprine (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Azithromycin/all macrolides (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Baclofen (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Bethanechol (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Bevacizumab (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Isoniazid/TB medication (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Magnesium sulfate (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Marijuana (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Meclizine (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Mefloquine (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Outlining adverse effects, allergies, and safety issues on Melatonin (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Recommending the optimal treatment options for Diabetes mellitus type 2 (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Recommending the optimal treatment options for Hemophilia A (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Recommending the optimal treatment options for Opioid overdose (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Development—Recommending the optimal treatment options for Vitamin B12 deficiency anemia (Assess The Patient's Health Status and Concerns; Development of care plan; Implementation of Plan; Administration of drugs)
  • Information—Labs or tests to order diabetes (Obtaining Information about the patient)
  • Information—Labs or tests to order in Cushing syndrome (Obtaining Information about the patient)
  • Information—Labs or tests to order in Graves disease (Obtaining Information about the patient)
  • Information—Labs or tests to order in osteomyelitis (Obtaining Information about the patient)
  • Information—Labs or tests to order in peptic ulcer disease (Obtaining Information about the patient)
  • Information—Labs or tests to order in renal failure (Obtaining Information about the patient)
  • Information—Labs or tests to order in rhabdomyolysis (Obtaining Information about the patient)
  • Information—Labs or tests to order in rheumatoid arthritis (Obtaining Information about the patient)
  • Information—Labs or tests to order in Sarcoidosis (Obtaining Information about the patient)
  • Information—Labs or tests to order in SLE (Obtaining Information about the patient)
  • Information—Labs or tests to order in syphilis (Obtaining Information about the patient)
  • Information—Labs or tests to order in UTI (Obtaining Information about the patient)
  • Information—Taking history of present illness (Obtaining Information about the patient)
  • Information—Taking history of sexual health and STDs (Obtaining Information about the patient)
  • Information—Taking pediatric history (Obtaining Information about the patient)

Product Distribution

  • Dispending Products- Tapering opioids (Dispensing a product safely and accurately)
  • Dispensing Products- Adverse consequences of nonmedical prescription opiates (Dispensing a product safely and accurately)
  • Dispensing Products- Albendazole dose and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Apothecary system (Dispensing a product safely and accurately)
  • Dispensing Products- Azithromycin dose and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Baclofen dose and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Body Surface Area (Dispensing a product safely and accurately)
  • Dispensing Products- Calculate the daily dose range of Amoxicillin in a child (Dispensing a product safely and accurately)
  • Dispensing Products- Calculate the dose of Acetaminophen in a child with fever (Dispensing a product safely and accurately)
  • Dispensing Products- Calculations in milliequivalents (Dispensing a product safely and accurately)
  • Dispensing Products- Calculations in milliosmoles (Dispensing a product safely and accurately)
  • Dispensing Products- Calculations in molarity (Dispensing a product safely and accurately)
  • Dispensing Products- Cockcroft-Gault Equation in decreased kidney function (Dispensing a product safely and accurately)
  • Dispensing Products- Desensitization Protocol in Allopurinol allergy (Dispensing a product safely and accurately)
  • Dispensing Products- Detecting prescription errors in dose (Dispensing a product safely and accurately)
  • Dispensing Products- Finasteride dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Fluconazole dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Flutamide dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Furosemide dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Glimepiride dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Infusion rate dosing calculation (Dispensing a product safely and accurately)
  • Dispensing Products- Memantine Hydrochloride dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Metaxalone dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Metformin dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- NAPRA’s compounding of hazardous non-sterile preparation (Dispensing a product safely and accurately)
  • Dispensing Products- NAPRA’s non-sterile compounds preparation (Dispensing a product safely and accurately)
  • Dispensing Products- Normality calculations (Dispensing a product safely and accurately)
  • Dispensing Products- Ondansetron dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Osmolarity considerations in infusion of medications (Dispensing a product safely and accurately)
  • Dispensing Products- Percentage Strengths (Dispensing a product safely and accurately)
  • Dispensing Products- Prepare and compound non-sterile and sterile products (Dispensing a product safely and accurately)
  • Dispensing Products- Ratio Strength and solubility ratios (Dispensing a product safely and accurately)
  • Dispensing Products- Salazar- Corcoran Equation in Obese patients (Dispensing a product safely and accurately)
  • Dispensing Products- Telmisartan dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- The allegation method (Dispensing a product safely and accurately)
  • Dispensing Products- Tizanidine hydrochloride dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Tolterodine tartrate dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Topiramate dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Training pharmacy technicians in detecting red flags in prescription (Dispensing a product safely and accurately)
  • Dispensing Products- Tranexamic acid dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Tylenol with codeine dose adjustments (Dispensing a product safely and accurately)
  • Dispensing Products- Understanding Units of medications: Insulin (Dispensing a product safely and accurately)
  • Dispensing Products- Understanding Units of medications: Nystatin (Dispensing a product safely and accurately)
  • Dispensing Products- Valacyclovir Hydrochloride dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Validity, Clarity, Completeness, and authenticity of prescription (Dispensing a product safely and accurately)
  • Dispensing Products- Valproate Sodium dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Verapamil Hydrochloride dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- Warfarin Sodium dosage and bioequivalence (Dispensing a product safely and accurately)
  • Dispensing Products- WHO guidelines for prescription errors (Dispensing a product safely and accurately)

Practice Setting

  • Practice Setting- All-pharmacy or company-wide time management integration (Optimize the safety, efficacy, and efficiency of operations)
  • Practice Setting- Benefits of being organized and managing the time well (Optimize the safety, efficacy, and efficiency of operations)
  • Practice Setting- Business legal structure: sole proprietorship (Optimize the safety, efficacy, and efficiency of operations)
  • Practice Setting- Franklin Covey method of time management (Optimize the safety, efficacy, and efficiency of operations)
  • Practice Setting- Point-of- sale (POS) benefits (Optimize the safety, efficacy, and efficiency of operations)
  • Practice Setting— Hospital pharmacy floor stock distribution system disadvantages (Optimize the safety, efficacy, and efficiency of operations)
  • Practice Setting— Hospital pharmacy unit dose distribution benefits (Optimize the safety, efficacy, and efficiency of operations)
  • Practice Setting— Pharmacy technicians in vaccine injections (Optimize the safety, efficacy, and efficiency of operations)
  • Practice Setting—ABC Analysis; VEN Analysis for inventory (Oversee pharmacy inventory to ensure safe and effective patient care)
  • Practice Setting—Class I recalls of drugs (Oversee pharmacy inventory to ensure safe and effective patient care)
  • Practice Setting—Class III recalls of drugs (Oversee pharmacy inventory to ensure safe and effective patient care)
  • Practice Setting—E-prescribing system advantages and disadvantages (Record keeping activities to ensure safe, effective, and patient care)
  • Practice Setting—Estimation of safety stock (Oversee pharmacy inventory to ensure safe and effective patient care)
  • Practice Setting—Management of drug shortages in disasters, pandemics, etc (Oversee pharmacy inventory to ensure safe and effective patient care)
  • Practice Setting—Unclaimed prescriptions that have not been picked up (Oversee pharmacy inventory to ensure safe and effective patient care)

Health Promotion

  • Alcohol misuse screening; Behavioral counseling (Participate in public health activities)
  • Beyond use date for immediate-use preparations (Contribute to the maintenance of a healthy environment for the public)
  • Beyond use date for preparations (Contribute to the maintenance of a healthy environment for the public)
  • Beyond use time of 12 hours or less for preparations compounded in segregated areas (Contribute to the maintenance of a healthy environment for the public)
  • Blood pressure in adults (Participate in public health activities)
  • Breast cancer screening (Participate in public health activities)
  • Canadian Society of Hospital Pharmacists (Engage in health promotion activities with the patient)
  • Child abuse screening (Participate in public health activities)
  • Childhood immunization requirements (Participate in public health activities)
  • Cholesterol abnormalities-screening (Participate in public health activities)
  • Colorectal cancer screening (Participate in public health activities)
  • Cost of illness: provider/hospital: medical and non-medical costs (Participate in public health activities)
  • Diabetes Mellitus -screening (Participate in public health activities)
  • Elder abuse screening (Participate in public health activities)
  • Emergency contraception (Engage in health promotion activities with the patient)
  • Environmental quality specifications: Ante room; supplies in the anteroom and supplies kept elsewhere; use of equipment in the anteroom; HVAC design (Contribute to the maintenance of a healthy environment for the public)
  • Environmental quality specifications: Direct compounding area; buffer area (Contribute to the maintenance of a healthy environment for the public)
  • Fall prevention; Osteoporosis screening (Participate in public health activities)
  • Four phases of disaster preparedness: Mitigation; Preparedness; Response; Recovery (Participate in public health activities)
  • Health Canada: New drug development and approval (Engage in health promotion activities with the patient)
  • Hepatitis C Virus screening (Participate in public health activities)
  • HIV screening (Participate in public health activities)
  • Lung cancer screening (Participate in public health activities)
  • Mass casualty triage algorithm SALT- Sort, Assess, Lifesaving Intervention, and Treatment/Transport (Participate in public health activities)
  • NAPRA requirements for personnel gloves and garbing; cleaning and disinfecting personnel competency (Contribute to the maintenance of a healthy environment for the public)
  • NAPRA's functional parameters for shared anteroom for the compounding of non-hazardous and hazardous sterile preparations (Contribute to the maintenance of a healthy environment for the public)
  • NAPRA's Functional parameters of the anteroom for the compounding of non-hazardous sterile preparations (Contribute to the maintenance of a healthy environment for the public)
  • NAPRA's functional parameters of the compounding clean room : Pressure, air change per hour, temperature (Contribute to the maintenance of a healthy environment for the public)
  • NAPRA's recommendations for maintenance of primary engineering control (Contribute to the maintenance of a healthy environment for the public)
  • NAPRA's recommendations for shared facilities: anteroom: non-hazardous and hazardous sterile preparations. (Contribute to the maintenance of a healthy environment for the public)
  • NAPRA's recommendations for Sterile compounding areas accessories such as ceiling fixtures and plumbing (Contribute to the maintenance of a healthy environment for the public)
  • NAPRA's recommendations for Sterile Compounding areas ceiling, walls, floors (Contribute to the maintenance of a healthy environment for the public)
  • NAPRA's recommendations for sterile recommendations for work surfaces, furniture, pass-through, and cart (Contribute to the maintenance of a healthy environment for the public)
  • NAPRA's recommendations for the Anteroom location, demarcation line, activities done there; items it must contain (Contribute to the maintenance of a healthy environment for the public)
  • Obesity in adults; counseling and intervention (Participate in public health activities)
  • Pharmacist role counseling regarding smoking in pregnancy (Engage in health promotion activities with the patient)
  • Pharmacist role in advising patients to see a dietician (Engage in health promotion activities with the patient)
  • Pharmacist role in counseling in the prevention of skin cancer; sun protection (Engage in health promotion activities with the patient)
  • Pharmacist role in counseling on alcohol use (Engage in health promotion activities with the patient)
  • Pharmacist role in counseling on energy drinks (Engage in health promotion activities with the patient)
  • Pharmacist role in counseling osteoporosis patients for health promotion (Engage in health promotion activities with the patient)
  • Pharmacist role in counseling regarding Folate intake in pregnancy (Engage in health promotion activities with the patient)
  • Pharmacist role in counseling regarding teratogenic drugs in pregnancy (Engage in health promotion activities with the patient)
  • Pharmacist role in counseling to reduce mortality In coronary heart disease (Engage in health promotion activities with the patient)
  • Pharmacist role in encouraging breastfeeding (Engage in health promotion activities with the patient)
  • Pharmacist role in encouraging flu vaccination (Engage in health promotion activities with the patient)
  • Pharmacist role in recommending exercise (Engage in health promotion activities with the patient)
  • Pharmacist role in reducing risks of falls in the elderly (Engage in health promotion activities with the patient)
  • Pharmacist role in secondary prevention of disease: Asthma (Engage in health promotion activities with the patient)
  • Pharmacist role in secondary prevention of disease: Dental Health (Engage in health promotion activities with the patient)
  • Pharmacist role in secondary prevention of disease: depression (Engage in health promotion activities with the patient)
  • Pharmacist role in secondary prevention of disease: Diabetes (Engage in health promotion activities with the patient)
  • Pharmacist role in secondary prevention of disease: High cholesterol (Engage in health promotion activities with the patient)
  • Pharmacist role in secondary prevention of disease: Hypertension (Engage in health promotion activities with the patient)
  • Phase I clinical trials (Participate in public health activities)
  • Phase IV clinical trials (Participate in public health activities)
  • Prevention influenza transmission (Contribute to the maintenance of a healthy environment for the public)
  • Prevention of COVID-19 and other potential pandemics (Contribute to the maintenance of a healthy environment for the public)
  • Prevention of entamoeba transmission (Contribute to the maintenance of a healthy environment for the public)
  • Prevention of gastroenteritis virus transmission (Contribute to the maintenance of a healthy environment for the public)
  • Prevention of Hepatitis A virus transmission (Contribute to the maintenance of a healthy environment for the public)
  • Prevention of Shingles transmission (Contribute to the maintenance of a healthy environment for the public)
  • Prevention of Streptococcal pneumonia transmission (Contribute to the maintenance of a healthy environment for the public)
  • Prevention of TB transmission (Contribute to the maintenance of a healthy environment for the public)
  • Promote safe storage, use, and disposal of medications (Contribute to the maintenance of a healthy environment for the public)
  • START triage system for pediatric patients in emergency casualty incident (Participate in public health activities)
  • STD screening and counseling (Participate in public health activities)
  • Tobacco use in adults; counseling and intervention (Participate in public health activities)
  • Travel prophylaxis requirements for hepatitis A (Participate in public health activities)
  • Travel prophylaxis requirements for malaria (Participate in public health activities)
  • Travel prophylaxis requirements for typhoid fever (Participate in public health activities)

Knowledge and Research Application

  • Absolute risk reduction or risk (Respond to questions using appropriate strategies)
  • Barriers to critical thinking: perceptions; poor metacognitive skills; fixed mindset; heuristics; biases; efforts involved in critical thinking (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Barriers to participation in clinical trials (Respond to questions using appropriate strategies)
  • Bayes Rule and Screening Tests: Negative predictive value (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Bayes Rule and Screening Tests: Positive predictive value (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Affective bias (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Ambiguity effect (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Anchoring (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Authority bias (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Availability bias (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Bandwagon effect (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Base-rate fallacy (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Blind-spot bias (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Choice-supportive bias (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: confirmation bias (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: conservatism bias (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: focusing effect (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: framing effect (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Gambler’s fallacy (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Halo effect (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: information bias (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Ostrich effect (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Outcome bias (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Overconfidence bias (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Pro-innovation bias (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Selective perception (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Stereotyping (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Survivorship bias (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Biases: Sutton’s slip (Apply knowledge, research-skills, and professional judgment to the decision-making process)
  • Clinical Trial Phase 1 (Respond to questions using appropriate strategies)
  • Clinical Trial Phase 2 (Respond to questions using appropriate strategies)
  • Clinical Trial Phase 3 (Respond to questions using appropriate strategies)
  • Clinical Trial Phase 4 (Respond to questions using appropriate strategies)
  • CONSORT checklist for consolidated standards of reporting trials (Respond to questions using appropriate strategies)
  • Critical Appraisal definition; distinguishing evidence of high quality and low quality; Facilitation in decision-making (Respond to questions using appropriate strategies)
  • Literacy assessment for diabetes (LAD); 60-item word measuring tool (Respond to questions using appropriate strategies)
  • Number needed to harm (Respond to questions using appropriate strategies)
  • Number needed to treat (Respond to questions using appropriate strategies)
  • Odds ratio (Respond to questions using appropriate strategies)
  • Pharmacist intervention to improve low health literacy (Respond to questions using appropriate strategies)
  • Pharmacovigilance in monitoring adverse drug reaction (Apply relevant information to practice)
  • Publication bias (Respond to questions using appropriate strategies)
  • RADAR test for (Respond to questions using appropriate strategies)
  • Rapid Estimate of Adult Literacy In Medicine (REALM) instrument measure (Respond to questions using appropriate strategies)
  • Relative risk reduction or benefit (Respond to questions using appropriate strategies)
  • Research ethics (Respond to questions using appropriate strategies)
  • ROOT-Relevance, Observed validity, Obtained Results, and Translation into practice (Respond to questions using appropriate strategies)
  • Sample size; Raosoft calculator; Margin of error (Apply relevant information to practice)
  • Software use for systematic literature: DistillerSR; EndNote; Mendeley; Zotero (Respond to questions using appropriate strategies)
  • SPIKES Method of breaking bad news to patients; giving information that is difficult to process; addressing developing serious side effects (Respond to questions using appropriate strategies)
  • Standard interval calculation (Apply relevant information to practice)
  • Strategies that improve health literacy through patient-centered communication framework; Goal oriented education; spoken and written (Respond to questions using appropriate strategies)
  • STROBE Checklist for cohort (Respond to questions using appropriate strategies)
  • Systematic Literature search: Biomedical databases: ; PubMed; MEDLINE; EMBASE; CINAHL; TRIP Database; NGC guidelines database; SCOPUS; Google scholar; Web of Science (Respond to questions using appropriate strategies)
  • Systematic literature search: Characteristics; reliability; validity; repeatability (Respond to questions using appropriate strategies)
  • Teach-back communication method for patient education; When to use it; can you tell what you need to do at home with the medications (Respond to questions using appropriate strategies)
  • Test of functional health literacy in adults (TOHFLA) (Respond to questions using appropriate strategies)
  • The Joanna Briggs Critical Appraisal Tools (Respond to questions using appropriate strategies)
  • The Mann-Whitney Test (Apply relevant information to practice)
  • The mean calculation and its uses (Apply relevant information to practice)
  • The median and its uses; Interquartile range and uses (Apply relevant information to practice)
  • The pyramid of quality of evidence from Case-control studies at the bottom, randomized trials in the middle; to systematic review at the top (Respond to questions using appropriate strategies)
  • Wide Range Achievement Test (WRAT); reading subtest (Respond to questions using appropriate strategies)

Communication and Education

  • Angry patient on the telephone; answer quickly; do not blame; don’t be defensive; keep promises or don’t make them; inform supervisor (Implement Safe, Effective, and Consistent Communication Systems)
  • Ask if the patient has any questions; look for nonverbal cues of lack of understanding; listen patient; then answer clearly (Deliver an education session to an individual or group)
  • Be Specific—no food or water after midnight; all antibiotics must be taken even after feeling better (Deliver an education session to an individual or group)
  • Choose a correct lay term for medical term “intermittent” (Establish and Maintain Effective Communication Skills)
  • Choose a correct lay term for the medical term “Analgesic” (Establish and Maintain Effective Communication Skills)
  • Choose a correct lay term for the medical term “Anticoagulant” (Establish and Maintain Effective Communication Skills)
  • Choose a correct lay term for the medical term “hypertension” (Establish and Maintain Effective Communication Skills)
  • Choose a correct lay term for the medical term “Sublingual” (Establish and Maintain Effective Communication Skills)
  • COMFORT communication curriculum (Establish and Maintain Effective Communication Skills)
  • Communication with English-limited patients (Deliver an education session to an individual or group)
  • Consequences of poor knowledge of medicines (Deliver an education session to an individual or group)
  • Correlation between medical errors and communication failures (Implement Safe, Effective, and Consistent Communication Systems)
  • Correlation between poor communication and patient complaints against health professionals (Establish and Maintain Effective Communication Skills)
  • Counseling the patient on drugs use, potential side effects, and the teach-me-back method (Establish and Maintain Effective Communication Skills)
  • Counseling the patient on lifestyle modification: best communication skills (Establish and Maintain Effective Communication Skills)
  • Demonstrate: How elderly patients can use walkers (Deliver an education session to an individual or group)
  • Encourage the patient to make a commitment; heart attack has to have low diet and exercise; mental illness has to take meds (Deliver an education session to an individual or group)
  • Fully inform the patient; effects; antidepressant may take weeks to effect change; SSRI don't relieve depression immediately like NSAIDs do pain (Deliver an education session to an individual or group)
  • History taking: Avoiding leading questions (Establish and Maintain Effective Communication Skills)
  • History taking: Being nonjudgmental in communication; avoiding criticism (Establish and Maintain Effective Communication Skills)
  • History Taking: Do not interrupt the patient; conversation sample that includes an interruption as wrong way to communicate; one question at a time (Establish and Maintain Effective Communication Skills)
  • History taking: FOSS or other mnemonics; Family history; ObGyn history; Sexual history; and social history (Establish and Maintain Effective Communication Skills)
  • History Taking: SAD PERSONS mnemonic for suicidality (Establish and Maintain Effective Communication Skills)
  • History taking: SIQORAAA or other mnemonic; history of present illness; site or symptom; impact or intensity; quality; onset; radiation (Establish and Maintain Effective Communication Skills)
  • History taking: The use of open and closed-ended questions (Establish and Maintain Effective Communication Skills)
  • History taking: Using lay language when speaking and appropriate use of medical terminology (Establish and Maintain Effective Communication Skills)
  • Identifying patients with undiagnosed COPD through frequent OTC cough medicines (Implement Safe, Effective, and Consistent Communication Systems)
  • Pill card to educate patients about their medications (Implement Safe, Effective, and Consistent Communication Systems)
  • Reading level of an older adult with high school diploma; consent forms language; medication label reading level (Deliver an education session to an individual or group)
  • The advantages and disadvantages of Fascimile and E-mail communication in healthcare (Implement Safe, Effective, and Consistent Communication Systems)
  • The impact of telephone use on non-verbal communication; the advantages and disadvantages of telephone in communication (Implement Safe, Effective, and Consistent Communication Systems)
  • The CARE questionnaire for empathy assessment (Establish and Maintain Effective Communication Skills)
  • The RESPECT model of communication: Rapport; Empathy; Support; Partnership; Explanations; Cultural competence; Trust (Establish and Maintain Effective Communication Skills)

Inter and Intra-professional collaboration

  • Cases to be referred to abdominal surgery (Accept and Make referrals for specific services)
  • Cases to be referred to cardiologist (Accept and Make referrals for specific services)
  • Cases to be referred to Emergency Medicine (Accept and Make referrals for specific services)
  • Cases to be referred to Endocrinology (Accept and Make referrals for specific services)
  • Cases to be referred to ENT (Accept and Make referrals for specific services)
  • Cases to be referred to gastroenterology (Accept and Make referrals for specific services)
  • Cases to be referred to Nephrology (Accept and Make referrals for specific services)
  • Cases to be referred to neurologist (Accept and Make referrals for specific services)
  • Cases to be referred to neurosurgery (Accept and Make referrals for specific services)
  • Cases to be referred to Obstetrics (Accept and Make referrals for specific services)
  • Cases to be referred to Ophthalmology (Accept and Make referrals for specific services)
  • Cases to be referred to Orthopedics (Accept and Make referrals for specific services)
  • Cases to be referred to Pediatrics (Accept and Make referrals for specific services)
  • Cases to be referred to primary care physician (Accept and Make referrals for specific services)
  • Cases to be referred to Psychiatry (Accept and Make referrals for specific services)
  • Cases to be referred to pulmonology (Accept and Make referrals for specific services)
  • Community acquired pneumonia (Accept and Make referrals for specific services)
  • Congestive heart failure (Accept and Make referrals for specific services)
  • Deep vein thrombosis (Accept and Make referrals for specific services)
  • Delirium tremens (Accept and Make referrals for specific services)
  • Diabetic ketoacidosis (Accept and Make referrals for specific services)
  • Disc herniation and cauda equina syndrome (Accept and Make referrals for specific services)
  • Dizziness and syncope (Accept and Make referrals for specific services)
  • Electrical injuries (Accept and Make referrals for specific services)
  • Factors influencing the acceptance of referrals for pharmacists (Accept and Make referrals for specific services)
  • Frequent falls (Accept and Make referrals for specific services)
  • Head injury or concussion (Accept and Make referrals for specific services)
  • Massive hemorrhage: GI, Vaginal, Hemoptysis (Accept and Make referrals for specific services)
  • Myocardial infarction (Accept and Make referrals for specific services)
  • Priapism (Accept and Make referrals for specific services)

Quality and Safety

  • . A patient with CHF is on digoxin 0.25 mg, HCTZ 50 mg , and a low Na ,K-rich diet. He develops polyarteritis. Which of the following steroids to give ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • 65-year old with COPD exacerbation prescribed Amoxicillin and Prednisolone for 7 days ; Pharmacist error in dispensing was Propranolol for 28 days (Contribute to continuous quality improvement and risk management activities related to pharmacy.)
  • 70 year old male weighing 60 kilograms was given slow release oral morphine tablets; 60 mg twice a day (Contribute to continuous quality improvement and risk management activities related to pharmacy.)
  • A bacterial agent that is particularly dangerous to the eye is which of the following ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A child who swallows an overdose of a fluoride-containing product should be treated with a gastric lavage containing what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A common measure in assessing the degree of AIDS patients is the determination of levels of what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A major of celecoxib over most other NSAIDs is that it can be described as what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A nutritional product contains 14 g of protein, 18 g of carbohydrate, and 10 g of fat in each 100-mL serving. Caloric content of a serving would be ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A patient experiencing signs of acute chlordiazepoxide (Librium) toxicity after taking 15 doses in a suicide attempt. An agent to administer is what? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A patient arriving in the emergency room with severe hypertensive crisis would most likely be treated with what medication ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A patient is admitted to the emergency room with marked hypotension and appears to be in shock. The drug of choice to treat the condition is probably what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A patient is said to have a significantly elevated PSA level. This could be indicative of what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A patient is to receive dalteparin sodium for prevention of deepvein thrombosis. Which of the following is true of dalteparin sodium? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A patient who has recently suffered Myocardial infarction will most likely elevation of which enzymes (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A patient who is a slow acetylator of isoniazid is characterized by what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A patient who is to use montelukast sodium (Singulair) should be advised to do what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A patient with fungal blepharitis should be treated with what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A patient with left ventricular failure is likely to exhibit what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • A patient with Parkinson's disease is likely to exhibit which of the following symptoms ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Add supplemental instructions; Tetracyclines need to avoid sun exposure; NSAIDs should be taken with food (Contribute to a culture of patient safety)
  • Adrenergic agonists; epinephrine; norepinephrine (Contribute to continuous quality improvement and risk management activities related to pharmacy.)
  • Adrenergic antagonists; Metoprolol; Propranolol (Contribute to continuous quality improvement and risk management activities related to pharmacy.)
  • Advantages of Acetaminophen over Aspirin (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Alteplase characteristics (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • An adult patient who ingested 30 Acetaminophen tablets of 325 mg about 6 hours ago should be treated with what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Anesthesia safety: 80% human error related in anesthesia; 20% equipment failure (Contribute to continuous quality improvement and risk management activities related to pharmacy.)
  • Anesthetic agents; Propofol; Ketamine (Contribute to continuous quality improvement and risk management activities related to pharmacy.)
  • Antiarrhythmic; Lidocaine; Amiodarone (Contribute to continuous quality improvement and risk management activities related to pharmacy.)
  • Antibiotics-induced pseudomembranous colitis should be treated by what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Antipsychotic drugs pharmacologic action (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Aspirin mechanism of action (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Clinical Trial Phase I involves administering the investigational drug to what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Clonidine mechanism of action (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Clopidogrel anticoagulation properties (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Dalteperin should be administered how ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Deferoxamine Mesylate is an antidote of what (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Drug Labeling, packaging, and nomenclature; drug names that look and sound alike; ambiguous drug packaging; mix-ups; similar shapes bottles; confirmation bias (Contribute to a culture of patient safety)
  • Drug used for the same purpose as Propylthiouracil (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Effects of Atropine on the human body (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Finasteride descriptions (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Hypothyroidism medications (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • In the treatment of acute hypertensive crisis, nitroprusside (Nitropress) is administered by which route ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Inotropic medications; Digoxin; Milrinone (Contribute to continuous quality improvement and risk management activities related to pharmacy.)
  • Insulin lispro (Humalog) is generally administered when ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Insulin preparations are usually administered by which route ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Insulin; subcutaneous and IV (Contribute to continuous quality improvement and risk management activities related to pharmacy.)
  • International Conference on Harmonization (ICH )Q1C (Ensure the quality, safety, and integrity of products)
  • International Conference on Harmonization (ICH) Q1A (Ensure the quality, safety, and integrity of products)
  • International Conference on Harmonization (ICH) Q1B (Ensure the quality, safety, and integrity of products)
  • Lactulose is used to treat what condition (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Liposomal forms of drugs; Amphotericin B (Contribute to continuous quality improvement and risk management activities related to pharmacy.)
  • Magnesium sulfate injection (Contribute to continuous quality improvement and risk management activities related to pharmacy.)
  • Masking the bitter tastes of drugs may be accomplished by using what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Miscellaneous combined- Benzodiazepines action (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Miscellaneous combined- Mechanism of action of Milrinone lactate (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Miscellaneous combined- Salmeterol indication; action; mechanism (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Oxytocin IV (Contribute to continuous quality improvement and risk management activities related to pharmacy.)
  • Pamidronate Sodium indications (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Patient has reddish discoloration of the urine. She is most likely taking what medication ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Patients diagnosed with Alzheimer’s disease may be treated with what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Patients on Lithium carbonate should be advised what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Patients using Alendronate should be advised to do what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Patients using amiodarone (Cordarone) should be monitored for what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Patients using Phenytoin should be monitored for the development of what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Patients who take Amiloride should be advised what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Permethrin descriptions (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Pharmaceutical Calculations: 250 mL infusion bottle contains 5.86 g of KCL; How many mEq are present if KCL molecular weight is 74.6 (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Pharmaceutical Calculations: Calcium Chloride (CaCl2 .H2O) has a formula of 147; What weight of the chemical needed to obtain 40 mEq of Calcium (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Pharmaceutical Calculations: Dose of a drug in 2 mg/kg/day in 175 lbs (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Pharmaceutical Calculations: How much Elemental Iron is present in 300 mg of Ferrous Sulfate (FeSO4. 7 H2O) (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Polycythemia refers to an elevated number of what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Prednisone indications (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Rapid reversal of Warfarin- induced hemorrhage can be accomplished by administration of what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Scabies is a contagious skin disease caused by what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Simvastatin mechanism of action (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Stenosis refers to what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Sumatriptan is most commonly indicated for what (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Tamoxifen characteristics (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • The best choice for a pregnant woman who s needs to be treated for essential hypertension is what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • The hematocrit measures what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • The most likely causative organism in an acute uncomplicated urinary tract infection is which one ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • The primary action of levobunolol in the treatment of glaucoma is by what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • The term "prodrug" refers to what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • The treatment of choice for Herpes simplex is what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • The use of angiotensin-converting enzyme (ACE) inhibitors is associated with what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Thiazides may produce what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • What are the types of cells that are included in White Blood Cell ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • What is indicated for the treatment of HIV ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • What is the name of the vaccine against Measles (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • What is the normal fasting blood glucose range ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • What should patients taking Rifampin be advised ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which Cephalosporin would be appropriate in CNS infections ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which drug is a selective serotonin reuptake inhibitors (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which name is Vitamin B1, B2, B6, and B12 (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following adverse effects is associated with the use of Cleocin? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following agent is classified as an immunosuppressive agent ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following agents are progestin only oral contraceptives ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following agents are used as an aid to smoking cessation? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following agents can be classified as an antagonist of Angiotensin II receptors ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following agents has the longest duration of effect as a bronchodilator? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following agents would be most dangerous to use in a patient already receiving high dose Gentamicin (kidney function) (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following antihypertensive agents is available as a transdermal dosage form ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following are appropriate agents to administer in treating severe hyperkalemia (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following best defines Hemochromatosis ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following drug products are indicated for use in Type 2 diabetes mellitus patients ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following drugs is associated with the "gray-baby syndrome" in infants? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following drugs is generally considered a drug of choice in treating status epilepticus? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following drugs would be most appropriate to use for the treatment of an uncomplicated gonorrhea infection in a poorly compliant patient? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following insulins would be expected to exert the longest duration of action? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following is (are) NOT typical signs or symptoms of Parkinson's disease? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following is a correct description of Sulfasalazine ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following is an indication for Bupropion HCl ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following is an indication for the use of Epoietin Alpha ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following is an opportunistic disease of AIDS ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following is benzodiazepines would be preferred as an anxiolytic drug for an elderly patient with a history of cirrhosis ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following is true of Clomiphene citrate ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following is true of Raloxifene (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following is true of Misoprostol ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following is true of orlistat (Xenical) (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following is true of parenterally administered Dilantin? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following is true of Zanamivir (Relenza) ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following medications is indicated for the treatment of Parkinson’s disease (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following Sulfonamides is best suited for topical prophylactic treatment of burns ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following therapeutic agents is specifically contraindicated for use in patients who have bronchial asthma (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following would be a good alternative to penicillin V in a pregnant patient allergic to penicillin ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which of the following would be appropriate for the treatment of candida vulvovaginitis ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which one of the following is a drug commonly used to treat trigeminal neuralgia (tic doloureux)? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Which preparation will induce passive rather than active immunity (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Why should TB medications be combined ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Zidovudine mechanism of action in HIV (Miscellaneous Combined Practice Questions/ Pharmacy Cards)
  • Zollinger-Ellison syndrome can be treated with what ? (Miscellaneous Combined Practice Questions/ Pharmacy Cards)